Posted On: 04/29/2016 6:12:47 AM
Post# of 72447
Additionally, just my .02 but that drug sucks when compared to K. First off, K has potential for use in 1/2 of all cancers while that drug was very specific for a small subset of lung cancer and only ~ 1/3 had a good response. Second, K is NON toxic while that drug caused pleural effusions which is really gonna hurt a patient already suffering from diminished lung function.
So the way I see it, we have the potential for much more dough.
So the way I see it, we have the potential for much more dough.
(1)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
